chlorambucil/dexamethasone/mitoxantrone

Known as: CLB/DHAD/DM 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2015
012319842015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE The objective of this study was to investigate stiripentol (STP) administration in cases of Dravet syndrome (DS) by… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2015
2015
AIM The aim of this study was to describe the pharmacokinetics of clobazam and its active metabolite N-desmethylclobazam (N-CLB… (More)
Is this relevant?
2015
2015
A new carrier-free catanionic drug-derivative nano-object strategy is developed for leukaemia therapy. The as-prepared drug… (More)
Is this relevant?
2012
2012
STUDY OBJECTIVE To investigate potential drug-drug interactions between clobazam and cytochrome P450 (CYP) isoenzyme substrates… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2011
2011
6629 Background: The FCR regimen (fludarabine, cyclophosphamide, rituximab) significantly improves the outcome of patients (pts… (More)
Is this relevant?
1990
1990
Steady state metabolite/parent drug plasma ratios were measured in 15 epileptic patients on carbamazepine (CBZ) monotherapy and… (More)
Is this relevant?
1984
1984
A monoclonal antibody, designated CLB-LFA-1/1, directed to the human lymphocyte-function-associated antigen 1 (LFA-1) was raised… (More)
Is this relevant?